AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer

Bo Chen1, Jin Wang1, Danian Dai1

  • 1Department of Breast Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 East Dongfeng Road, Guangzhou, 510060, People's Republic of China.

Abstract

Insights

The AHNAK protein acts as a tumor suppressor in triple-negative breast cancer (TNBC). Its down-regulation correlates with poor prognosis, while its restoration inhibits TNBC cell growth and metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • AHNAK (desmoyokin) is a large protein implicated in various cancer functions.
  • Its role in triple-negative breast cancer (TNBC) remains to be fully elucidated.

Purpose of the Study:

  • To investigate the role of AHNAK in triple-negative breast cancer (TNBC).
  • To determine the prognostic significance of AHNAK expression in TNBC patients.

Main Methods:

  • Analysis of AHNAK mRNA levels in breast cancer cell lines and patient tumors.
  • Correlation analysis between AHNAK expression and clinicopathological features in TNBC.
  • In vitro and in vivo functional assays of AHNAK in TNBC cell lines.
  • Investigation of signaling pathways involved in AHNAK's tumor-suppressive effects.

Main Results:

  • AHNAK mRNA was down-regulated in most human breast cancer cell lines, particularly in TNBC.
  • Reduced AHNAK expression correlated significantly with advanced tumor status, lymph node infiltration, and TNM stage in TNBC patients.
  • AHNAK overexpression suppressed TNBC cell proliferation, colony formation, xenograft growth, and lung metastasis.
  • AHNAK knockdown yielded consistent results, confirming its tumor-suppressive role.

Conclusions:

  • AHNAK functions as a tumor suppressor in triple-negative breast cancer.
  • Down-regulation of AHNAK is an independent prognostic factor for poor survival in TNBC patients.
  • AHNAK exerts its tumor-suppressive effects by modulating the AKT/MAPK and Wnt/β-catenin signaling pathways.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.5K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K